ask="N/A"
ask_size="N/A"
average_daily_volume="3950"
bid="0.0100"
bid_size="4000"
book_value="0.0000"
change="-0.0748"
change_from_200_day_moving_average="-0.3980"
change_from_50_day_moving_average="-1.3866"
change_from_52_week_high="-16.2448"
change_From_52_week_low="1.8252"
change_in_percent="-2.4686%"
close="2.9552"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.2000"
high_52_weeks="19.2000"
last_trade_date="2/8/2017"
last_trade_price="2.9552"
last_trade_size="250"
last_trade_time="3:51pm"
low="2.8408"
low_52_weeks="1.1300"
market_capitalization="N/A"
moving_average_200_day="3.3532"
moving_average_50_day="4.3418"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="N/A"
open="3.2000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-11.8695%"
percent_change_from_50_day_moving_average="-31.9364%"
percent_change_from_52_week_high="-84.6083%"
percent_change_from_52_week_low="+161.5221%"
previous_close="3.0300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="GALTU"
volume="4129"
weeks_range_52="1.1300 - 19.2000"
